Question

PLEASE HELPPPP ME :OOOOOO

In this project, you will research sickle cell anemia in Africa and how it relates to malaria. Write a 350 word report on the description of the disease sickle cell anemia and how it protects those that carry the gene against malaria. Include information such as which populations are most affected and how the environment determines whether the disease is beneficial or harmful.

Answer 1

Identifying common genetic variants underlying chronic non-communicable diseases, but has proved to be more difficult for acute infectious diseases that represent a substantial portion of the global disease burden and are most prevalent in tropical regions. This is partly due to the practical difficulties of establishing large sample collections and reliable phenotypic datasets in resource-constrained settings, but also theoretical and methodological challenges associated with the study of pathogenic diseases in populations with high levels of genetic diversity and population structure1,2,3. The Malaria Genomic Epidemiology Network (MalariaGEN) was established in 2005 to overcome these obstacles with standardized protocols, common phenotypic definitions, agreed policies for equitable data sharing, and local capacity building for genetic data analysis, enabling large collaborative studies across different countries where malaria is endemic4.

Here we extend previous work by using data collected from 11 countries to perform a comprehensive GWAS of human resistance to severe malaria (SM).

Answer 2

Step-by-step explanation:

identifying common genetic variants underlying chronic non-communicable diseases, but have proved to be more difficult for acute infectious diseases that represent a substantial portion of the global disease burden and are most prevalent in tropical regions. This is partly due to the practical difficulties of establishing large sample collections and reliable phenotypic datasets in resource-constrained settings, but also theoretical and methodological challenges associated with the study of pathogenic diseases in populations with high levels of genetic diversity and population structure1,2,3. The Malaria Genomic Epidemiology Network (MalariaGEN) was established in 2005 to overcome these obstacles with standardized protocols, common phenotypic definitions, agreed policies for equitable data sharing and local capacity building for genetic data analysis, enabling large collaborative studies across different countries where malaria is endemic4.

Here we extend previous work by using data collected from 11 countries to perform a comprehensive GWAS of human resistance to severe malaria (SM)